Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 15, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 17, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000816956-26-000096
Filed / recorded
Jul 17, 2026, 7:09 PM UTC
Added to OQRO
Oct 6, 2026, 10:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CONMED Corp
Issuer CIK
816956
Ticker
CNMD
Reporting person
John E Gallagher
Relationship
Officer
Officer title
Executive Vice President & CFO
Security
RSUs (Restricted Stock Units)
Table
Derivative (Table II)
Transaction date
Jul 15, 2026
Transaction code
A
Shares / units
35,054
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
35,054
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
9 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 13, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
9 tracked managers disclosed the same change for Q2 2026. From a 13F filed Jul 30, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade. A share price line is a session where the close moved at least 10% and four times its usual daily change.
The company's last weighty Form 8-K report up to this date: changed a top executive or board member, 28 days earlier (Jun 17, 2026). The first one after it: reported its results, 14 days later (Jul 29, 2026).